Download PDF
Thromb Haemost 1962; 07(01): 169-187
DOI: 10.1055/s-0038-1655463
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

Changes in the Activity of Clotting Factors in Relation to the Onset of Platelet Clumping and Fibrin Formation

J. F Mustard   *
1   Department of Medicine, University of Toronto, Sunnybrook Hospital, Department of Veterans Affairs, Toronto
,
T. D Hoeksema
1   Department of Medicine, University of Toronto, Sunnybrook Hospital, Department of Veterans Affairs, Toronto
› Author Affiliations
Further Information

Publication History

Publication Date:
21 June 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

The relationship has been studied between changes in clotting factors and the onset of platelet clumping and fibrin formation during the clotting of normal and pathological blood. In normal blood, glass activation factor activity, factor IX activity and platelet adhesiveness were found to increase prior to the onset of platelet clumping. There was no change in factor VIII or factor V activity until after the onset of platelet clumping. At about this point, detectable thrombin formation occurred and this was shortly followed by the onset of macroscopic fibrin formation. After fibrin formation, there was an increase in factor VII activity and a fall in factor IX activity. This fall in factor IX activity did not occur during the clotting of platelet poor normal plasma.

During the clotting of haemophilia A blood, there were similar changes to those seen with normal blood, except that the time of onset of platelet clumping was greatly delayed and the degree of change was often much less. When haemophilia B blood clotted, there was a temporary increase in factor IX activity at the point of platelet clumping which was closely followed by a marked decrease in factor IX activity. This decrease in factor IX activity was not found during the clotting of platelet poor haemophilia B plasma. Another difference was that factor VII activity decreased following the onset of fibrin formation.

In PTA blood the major difference from normal appeared to be a delayed activation of factor IX.

* Senior Research Associate, National Heart Foundation.


 

  • References

  • 1 Alexander B, Goldstein R, Rich L, le Bolloch A. G, Diamond L. K, Borges W. Congenital Afibrinogenemia. A study of some basic aspects of coagulation. Blood 1954; 9: 843
    PubMedGoogle Scholar
  • 2 Bell W. N, Alton H. G. Christmas disease associated with Factor VII deficiency: Case report with family survey. Brit. med. J 1955; 1: 330
    CrossrefPubMedGoogle Scholar
  • 3 Benny W. E, Lewis F. J. W. Christmas Factor (IX) defect in a case of haemorrhagic thrombocythaemia. J. clin. Path 1959; 12: 551
    CrossrefPubMedGoogle Scholar
  • 4 Bergsagel D. E. Viscous metamorphosis of platelets: Morphological platelet changes induced by an intermediate product of blood thromboplastin formation. Brit. J. Haemat 1956; 2: 130
    CrossrefPubMedGoogle Scholar
  • 5 Biggs R, Macfarlane R. G. Human blood coagulation and its disorders. Second edit. Blackwell; Oxford: 1957
    Google Scholar
  • 6 Biggs R, Sharp A. A, Margolis J, Hardisty R. M, Stewart J, Davidson R. N. Defects in the early stages of blood coagulation: A report of four cases. Brit. J. Haemat 1958; 4: 177
    CrossrefPubMedGoogle Scholar
  • 7 Connor W. E, Warner E. D, Carter J. R. A labile serum factor clotting defect: Its demonstration by the thromboplastin generation test and its clinical significance. J. clin. Invest 1961; 40: 13
    CrossrefPubMedGoogle Scholar
  • 8 Douglas A. S. Factor V consumption during blood coagulation. Brit. J. Haemat 1956; A 2: 153
    CrossrefPubMedGoogle Scholar
  • 9 Douglas A. S. Antihaemophilic globulin consumption during blood coagulation. Blood 1956; B 11: 423
    PubMedGoogle Scholar
  • 10 Hardisty R. M, Margolis J. The role of Flageman factor in the initiation of blood coagulation. Brit. J. Haemat 1959; 5: 203
    CrossrefPubMedGoogle Scholar
  • 11 Hougie C. Studies on the fate of coagulation factors during the clotting of normal and pathological blood. Thromb. Diath. haem 1959; 3: 578
    PubMedGoogle Scholar
  • 12 Johnston C. L, Ferguson J. H, O’Hanlon F. A, Black W. L. The fate of Factor VII and Stuart Factor during the clotting of normal blood. Thromb. Diath. haem 1959; 3: 367
    PubMedGoogle Scholar
  • 13 Lewis J. H, Didisheim P, Ferguson J. H, Hattori K. Changes occurring during coagulation in glass. 1. Normal blood. Thromb. Diath. haem 1959; 4: 1
    PubMedGoogle Scholar
  • 14 Margolis J. Initiation of blood coagulation by glass and related surfaces. J. Physiol 1957; 137: 95
    CrossrefPubMedGoogle Scholar
  • 15 McClure P, Mustard J. F. Unpublished observations
    PubMed
  • 16 Moollen S.E, Vroman L. Adhesiveness of blood platelets in thromboembolism and haemorrhagic disorders: Measurement of platelet adhesiveness by glass wool filter. Amer. J. clin. Path 1949; 19: 701
    PubMedGoogle Scholar
  • 17 Mustard J. F. Changes in the platelet levels of non-transfused patients following surgical operations. Acta haemat. (Basel) 1957; 17: 257
    CrossrefPubMedGoogle Scholar
  • 18 Mustard J. F. Increased activity of the coagulation mechanism during alimentary lipemia: Its significance with regard to thrombosis and atherosclerosis. Canad. med. Ass. J 1957; 77: 303
    PubMedGoogle Scholar
  • 19 Mustard J. F. The serum defect in Christmas disease. Acta haemat. (Basel) 1959; 21: 321
    CrossrefPubMedGoogle Scholar
  • 20 Mustard J. F, Hoeksema T. D, Secord D, Rowsell H. C, Downie H. G. Canine factor VII deficiency. Brit. J. Haemat 1962; 8: 43
    CrossrefPubMedGoogle Scholar
  • 21 Ollendorff P. Platelet activity and activation of blood by glass. Thromb. Diath. haem 1960; 4: 410
    PubMedGoogle Scholar
  • 22 Penick G. D. Some factors that influence utilization of antihaemophilic activity during clotting. Proc. Soc. exp. Biol. (N. Y.) 1958; 96: 280
    PubMedGoogle Scholar
  • 23 Pitney W. R. The assay of antihaemophilic globulin (AHG) in plasma. Brit. J. Haemat 1956; 2: 3
    PubMedGoogle Scholar
  • 24 Ratnoff O. D, Davie E. W, Mallett D. L. Studies on the action of Hageman Factor: Evidence that activated Hageman Factor in turn activates plasma thromboplastin antecedent. J. clin. Invest 1961; 40: 803
    CrossrefPubMedGoogle Scholar
  • 25 Seegers W. H, Alkjaersig N, Johnson S. A. Formation of Autoprothrombin I in solutions containing purified prothrombin and purified platelet factor 3. Amer. J. Physiol 1955; 181: 589
    PubMedGoogle Scholar
  • 26 Seegers W. H, Johnson S. A. Conversion of prothrombin to Autoprothrombin II (platelet cofactor II) and its relation to blood clotting mechanisms. Amer. J. Physiol 1956; 184: 259
    PubMedGoogle Scholar
  • 27 Sharp A. A. Viscous metamorphosis of blood platelets: Study of the relationship to coagulation factors and fibrin formation. Brit. J. Haemat 1958; 4: 28
    CrossrefPubMedGoogle Scholar
  • 28 Soulier J. P, Prou-Wartelle O, Ménaché D. Hageman trait and PTA deficiency: The role of contact of blood with glass. Brit. J. Haemat 1959; 5: 121
    CrossrefPubMedGoogle Scholar
  • 29 Soulier J. P, Prou-Wartelle O. New data on Hageman factor and plasma thromboplastin antecedent: The role of “contact” in the initial phase of blood coagulation. Brit. J. Haemat 1960; 6: 88
    CrossrefPubMedGoogle Scholar
  • 30 Spaet T. H. Anticoagulants derived from blood platelets. J. appl. Physiol 1957; 11: 19
    PubMedGoogle Scholar
  • 31 Surgenor D. M, Steele B. B, Wallach D. F. H. Thrombin formation in purified systems. Thromb. Diath. haem 1959; 4: 214
    PubMedGoogle Scholar
  • 32 Surgenor D. M, Wilson N. A, Henry A. S. Factor V from human plasma. Thromb. Diath. haem 1960; 5: 1
    PubMedGoogle Scholar
  • 33 White S. G, Aggeler P. M, Glendening M. B. Plasma thromboplastin component (PTC). A hitherto unrecognized blood coagulation factor. Blood 1953; 8: 101
    PubMedGoogle Scholar
  • 34 Zucker M. B, Borrelli J. Viscous metamorphosis produced by chilling and by clotting. Failure to find specific defect of viscous metamorphosis in PTA syndrome. Thromb. Diath. haem 1960; 4: 424
    PubMedGoogle Scholar